68
68
Growth Score
-19 pts
Heat Score
-16 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
169260
Biohaven develops clinical-stage therapies for neuroscience, immunology, obesity and oncology across rare and common diseases.
About the Company
Biohaven develops clinical-stage therapies targeting neuroscience, immunology, obesity and oncology. The company advances small molecules, protein therapeutics and bispecific degraders through proprietary platforms including Kv7 ion channel modulators, TRPM3 antagonists, MoDE and MATE. Its pipeline addresses conditions such as epilepsy,
spinocerebellar ataxia, spinal muscular atrophy, pain disorders, major depressive disorder, obesity, Parkinson’s disease, Alzheimer’s disease, multiple sclerosis, autoimmune diseases and IgA nephropathy. Biohaven also collaborates with academic and industry partners to license and develop novel mechanisms of action.
